Preoperative Oral Hydration in the Ambulatory Arthroplasty Population

June 19, 2023 updated by: Jose Rodriguez, Hospital for Special Surgery, New York

Preoperative Oral Hydration in the Ambulatory Arthroplasty Population :A Single-Blinded Randomized Control Trial

The purpose of this study is to investigate if the consumption of a complex carbohydrate drink preoperatively, decreases the length of stay and causes for failure to launch in patients undergoing ambulatory total joint arthroplasty.

Study Overview

Status

Recruiting

Detailed Description

The way total joint arthroplasty is practiced continues to evolve as CMS removed total hip arthroplasty (THA) from the inpatient-only list and added total knee arthroplasty (TKA) to the ASC Covered Surgical Procedures List (CPL) in 2020. Thus, surgeons must find subtle interventions that improve patient outcomes while minimizing the risk of adverse reactions. Current literature has not assessed the influence of preoperative hydration, using a complex carbohydrate drink, on the same-day discharge rate and causes for failure to launch. Considering variabilities in perioperative fluid management leading to postoperative nausea, vomiting, and dizziness, the investigators seek to reduce the incidence of these events by optimizing patients using a preoperative oral hydration protocol, reducing the length of stay, and improving same-day discharge rates.

Study Type

Interventional

Enrollment (Estimated)

312

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Ricardo Torres-Ramirez, BS
  • Phone Number: 212-260-3763
  • Email: torresr@hss.edu

Study Locations

    • New York
      • New York, New York, United States, 10021
        • Recruiting
        • Hospital for Special Surgery
        • Contact:
        • Sub-Investigator:
          • Samuel Rodriguez, MD
        • Sub-Investigator:
          • Alejandro Gonzalez Della Valle, MD
        • Sub-Investigator:
          • Michael Ast, MD
        • Sub-Investigator:
          • Stravos Memtsoudis, MD
        • Sub-Investigator:
          • Ricardo Torres, BS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Candidates for ambulatory total knee arthroplasty
  • Candidates for ambulatory total hip arthroplasty
  • Candidates for ambulatory revision knee arthroplasty (liner exchange only)
  • Candidates for ambulatory revision hip arthroplasty (liner exchange only)
  • Case scheduled before noon (12 pm)
  • Patient agrees to same-day discharge and has a responsible adult to spend the night on the day of discharge

Exclusion Criteria:

  • BMI less than 18.5 or greater than 37.0
  • Patients with diabetes, chronic kidney disease, clotting disorders, or neurological conditions preventing control of the affected limb.
  • Pregnant women
  • Patients scheduled as ambulatory due to insurance mandates
  • Patients with a history of active ischemia, significant valvular disease, significant arrhythmias, obstructive sleep apnea as per Hospital for Special Surgery guidelines, chronic opioid dependence (chronic daily opioid use for six or more months), and glomerular filtration rate < 60ml/min.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Complex Carbohydrate Drink Group
The patients will drink a 400ml drink that contains 50g of complex carbohydrates, 3 hours prior to the surgery. The drink will be given once at the preoperative holding area. Patients are not allowed to eat solid foods after 12am the morning of surgery and can only drink clear fluids up to 3 hours prior to the surgery.
Patients will drink a complex carbohydrate drink 3 hours before surgery. Drink to be given at the preoperative holding area.
No Intervention: No-Complex Carbohydrate Drink Group
These patients will follow normal institutional preoperative fluid management guidelines, this consist of no solid foods after 12am the morning of surgery. Patients are allowed to drink clear liquids (water, clear fruit juices, coffee) from 12am the morning of surgery up to 3 hours prior to the surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay in hours
Time Frame: From admission to discharge, up to 1 week
Length of hospital stay in hours, assess by medical record.
From admission to discharge, up to 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Same day discharge rate
Time Frame: Through study completion, an average of 3 months.
Percentage of patients discharged successfully the day of surgery.
Through study completion, an average of 3 months.
Number of physical therapy sessions attempted
Time Frame: From admission to discharge, up to 1 week.
Number of physical therapy sessions attempted, assess by medical record.
From admission to discharge, up to 1 week.
Total distance walked
Time Frame: From admission to discharge, up to 1 week.
Total distance walked during physical therapy attempts, assess by medical record.
From admission to discharge, up to 1 week.
Number of stairs climbed
Time Frame: From admission to discharge, up to 1 week.
Number of stairs climbed during physical therapy attempts, assess by medical record.
From admission to discharge, up to 1 week.
Orthostatic hypotension episodes
Time Frame: During physical therapy attempts, from admission to discharge.
Orthostatic hypotension episodes during physical therapy attempts, assess by medical record.
During physical therapy attempts, from admission to discharge.
HOOS JR Score
Time Frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.
This is a 6-item questionnaire that assesses patient-reported hip pain and function. Score ranges from 0-100, with 100 representing the best possible score.
The morning of surgery and at the first post-operative visit, up to 4 months post-op.
KOOS JR Score
Time Frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.
This is a 6-item questionnaire that assesses patient reported knee pain and function. Score ranges from -100, with 100 representing the best score possible.
The morning of surgery and at the first post-operative visit, up to 4 months post-op.
VR-12 Score
Time Frame: The morning of surgery and at the first post-operative visit, up to 4 months post-op.
The VR-12 is a 12-item self-reported questionnaire that assesses the patient physical and mental quality of life.
The morning of surgery and at the first post-operative visit, up to 4 months post-op.
Urine osmolality
Time Frame: Measured preoperatively the morning of surgery.
Urine osmolality taken preoperatively, assess by medical record.
Measured preoperatively the morning of surgery.
Urine specific gravity
Time Frame: Measured preoperatively the morning of surgery.
Urine specific gravity preoperatively, assess by medical record.
Measured preoperatively the morning of surgery.
In-house costs
Time Frame: From admission to discharge, up to 1 week.
In-house costs taking into account cost of complex carbohydrate drink vs previously published costs savings per night of stay.
From admission to discharge, up to 1 week.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jose A Rodriguez, MD, Hospital for Special Surgery, New York

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2022

Primary Completion (Estimated)

January 24, 2024

Study Completion (Estimated)

January 24, 2024

Study Registration Dates

First Submitted

August 24, 2022

First Submitted That Met QC Criteria

August 25, 2022

First Posted (Actual)

August 30, 2022

Study Record Updates

Last Update Posted (Actual)

June 22, 2023

Last Update Submitted That Met QC Criteria

June 19, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Length of Stay

Clinical Trials on Complex Carbohydrate Drink

3
Subscribe